Bioextrax AB (publ)

Stockholm Stock Exchange BIOEX.ST

Bioextrax AB (publ) EBIT Margin for the year ending December 31, 2023: -1,046.06%

Bioextrax AB (publ) EBIT Margin is -1,046.06% for the year ending December 31, 2023, a 77.87% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Bioextrax AB (publ) EBIT Margin for the year ending December 31, 2022 was -4,725.82%, a -23.78% change year over year.
  • Bioextrax AB (publ) EBIT Margin for the year ending December 31, 2021 was -3,818.00%, a 85.07% change year over year.
  • Bioextrax AB (publ) EBIT Margin for the year ending December 31, 2020 was -25,573.09%.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
SV Wall Street
Stockholm Stock Exchange: BIOEX.ST

Bioextrax AB (publ)

CEO Mr. Edvard Hall
IPO Date April 28, 2020
Location Sweden
Headquarters Skiffervägen 76
Employees 13
Sector Health Care
Industries
Biotechnology Oil Extraction Paper & Forest Products
Description

Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.

StockViz Staff

February 5, 2025

Any question? Send us an email